Cytotoxicity and genotoxicity reporter systems based on the use of mammalian cells

Advances in Biochemical Engineering/Biotechnology

Volumn 118, Issue , 2010, Pages 113-151

  Baumstark Khan, Christa ^a   Hellweg, Christine E ^a   Reitz, Günther ^a  

^a GERMAN AEROSPACE CENTER DLR   (Germany)

Author keywords

Cytotoxicity; DNA damage and repair; Genotoxicity; Mammalian cells; Reporter assays

Indexed keywords

CYTOTOXIN;

ANIMAL; ARTICLE; CELLS; CYTOLOGY; DRUG EFFECT; HUMAN; MAMMAL; METABOLISM; METHODOLOGY; MUTAGEN TESTING;

ANIMALS; CELLS; CYTOTOXINS; HUMANS; MAMMALS; MUTAGENICITY TESTS;

MAMMALIA;

EID: 77955541434     PISSN: 07246145     EISSN: None     Source Type: Book Series    
DOI: 10.1007/10_2009_20     Document Type: Article

References (218)

1. Foth H, Hayes A (2008) Concept of REACH and impact on evaluation of chemicals. Hum Exp Toxicol 27:5-21.
2. Kirkland D, Aardema M, Henderson L, Muller L (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutat Res 584:1-256.
3. Kirkland D, Aardema M, Muller L, Makoto H (2006) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Mutat Res 19:29-42.
4. Trevan JW (1927) The error of determination of toxicity. Proc R Soc Ser B Biol Sci 101:483-514.
5. OECD (Organisation for Economic Cooperation and Development) (1987). Guideline for Testing of Chemicals - Acute Oral Toxicity. OECD Guideline 401
6. Cutler D (2001) Death of LD50. Trends Pharmacol Sci 22:62.
7. OECD (Organisation for Economic Cooperation and Development) (2001). Updated guideline for testing of chemicals - acute oral toxicity-fixed dose method. OECD Guideline 420
8. OECD (Organisation for Economic Cooperation and Development) (2001). Updated guide-line for the testing of chemicals - acute oral toxicity-acute toxic class method. OECD Guideline 423
9. OECD (Organisation for Economic Cooperation and Development) (1998). Guideline for the testing of chemicals - acute oral toxicity: up-and-down procedure. OECD Guideline 425
10. Goodman G, Wilson R (1999) Predicting the carcinogenicity of chemicals in humans from rodent bioassay data. Environ Health Perspect 94:195-218.
11. Monro A (1996) Are lifespan rodent carcinogenicity studies defensible for pharmaceutical agents? Exp Toxicol Pathol 48:155-166.
12. Rack L, Spira H (1989) Animal rights and modern toxicology. Toxicol Ind Health 5:133-143.
13. Spielmann H (2002) A chair on alternatives? ALTEX 19:69-73.
14. Balls M, Straughan DW (1996) The three Rs of Russell & Burch and the testing of biological products. Dev Biol Stand 86:11-18.
15. Kreeftenberg JG (1999) Developments in the reduction refinement and replacement of animal tests in the quality control of immunobiologicals. Dev Biol Stand 101:17.
16. van der Kamp MD (1996) Replacement, reduction or refinement of animal use in the quality control of veterinary vaccines: development, validation and implementation. Dev Biol Stand 86:73-76.
17. Nath J, Krishna G (1998) Safety screening of drugs in cancer therapy. Acta Haematol 99:138-147.
18. Puck TT, Monro A (1955) A rapid method for viable cell titration and clone production with HeLa cells in tissue culture: the use of X-irradiated cells to supply conditioning factors. Proc Natl Acad Sci USA 103:432-437.
19. Puck TT, Monro A (1956) Action of X-rays on mammalian cells. J Exp Med 103:653-666.
20. Johnson TR, Massey RJ, Deinhardt F (1972) Lymphocyte and antibody cytotoxicity to tumor cells measured by a micro-51 chromium release assay. Immunol Commun 1:247-261.
21. Zarling JM, McKeough M, Bach FH (1976) A sensitive micromethod for generating and assaying allogeneically induced cytotoxic human lymphocytes. Transplantation 21:468-476.
22. 0-deoxyuridine for the measurement of DNA synthesis in mammalian cells in vitro. Can J Biochem Physiol 41:2343-2351.
23. Kangas L, Gronroos M, Nieminen AL (1984) Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. Med Biol 62:338-343.
24. Kuzmits R, Aiginger P, Muller MM, Steurer G, Linkesch W (1986) Assessment of the sensitivity of leukaemic cells to cytotoxic drugs by bioluminescence measurement of ATP in cultured cells. Clin Sci 71:81-88.
25. Lundin A, Hasenson M, Persson J, Pousette A (1986) Estimation of biomass in growing cell lines by adenosine triphosphate assay. Methods Enzymol 133:27-42.
26. Thore A, Anséhn S, Lundin A, Bergman S (1975) Detection of bacteriuria by luciferase assay of adenosine triphosphate. J Clin Microbiol 1:1-8.
27. Untch M, Sevin BU, Perras JP, Angioli R, Untch A, Hightower RD, Koechli O, Averette HE (1994) Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assay. Gynecol Oncol 53:44-49.
28. Kurbacher CM, Cree IA (2005) Chemosensitivity testing using microplate adenosine tri- phosphate-based luminescence measurements. Methods Mol Med 110:101-120.
29. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
30. Hayon T, Dvilansky A, Shpilberg O, Nathan I (2003) Appraisal of the MTT-based assay as a useful tool for predicting drug chemosensitivity in leukemia. Leuk Lymphoma 44:1957-1962.
31. Shimoyama Y, Kubota T, Watanabe M, Ishibiki K, Abe O (1989) Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay. J Surg Oncol 41:12-18.
32. Borenfreund E, Babich H, Martin-Alguacil N (1990) Rapid chemosensitivity assay with human normal and tumor cells in vitro. In Vitro Cell Dev Biol 26:1030-1034.
33. Borenfreund E, Shopsis C (1985) Toxicity monitored with a correlated set of cell-culture assays. Xenobiotica 15:705-711.
34. Korzeniewski C, Callewaert DM (1983) An enzyme-release assay for natural cytotoxicity. J Immunol Methods 64:313-320.
35. Skreb Y, Habazin-Novak V (1975) Reversible inhibition of DNA, RNA and protein synthe- sis in human cells by lead chloride. Toxicology 5:167-174.
36. Rink H, Baumstark-Khan C, Partke HJ (1986) Radiation induced formation of giant cells (Saccharomyces uvarum): IV. Macromolecular synthesis and protein patterns. Radiat Envi-ron Biophys 25:81-91.
37. Baumstark-Khan C, Hellweg CE, Scherer K, Horneck G (1999) Mammalian cells as biomonitors of UV-exposure. Anal Chim Acta 387:281-287.
38. Lockshin RA, Osborne B, Zakeri Z (2000) Cell death in the third millennium. Cell Death Differ 7:2-7.
39. Hetz C (2008) Apoptosis, necrosis and autophagy: from mechanisms to biomedical applications. Curr Mol Med 8:76-77.
40. Vermes I, Haanen C, Reutelingsperger C (2000) Flow cytometry of apoptotic cell death. J Immunol Methods 243:167-190.
41. Dearfield KL (1995) Information requirements and regulatory approaches for heritable genetic risk assessment and risk communication. Mutat Res 330:35-40.
42. Battershill JM, Fielder RJ (1998) Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice. Hum Exp Toxicol 17:193-205.
43. Bulman RA, Dragani TA, Bouffler SD, Cox R (2006) Locations of mouse DNA damage response and repair loci, and cancer risk modifiers. DNA Repair 5:274-277.
44. Naccarati A, Pardini B, Hemminki K, Vodicka P (2007) Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutat Res 635:118-145.
45. Pastwa E, Somiari RI, Malinowski M, Somiari SB, Winters TA (2009) In vitro non- homologous DNA end joining assays the 20th anniversary. Int J Biochem Cell Biol 41:1254-1260.
46. Hoeijmakers JHJ (2001) Genome maintenance mechanisms for preventing cancer. Nature 411:366-374.
47. Baumstark-Khan C (1993) X-ray-induced DNA double-strand breaks as lethal lesions in diploid human fibroblasts compared to chinese hamster ovary cells. Int J Radiat Biol 63:305-311.
48. Baumstark-Khan C (1992) Effect of aphidicolin on DNA synthesis, PLD recovery and DNA repair of a human diploid cell line. Int J Radiat Biol 61:191-197.
49. Blocher D, Pohlit W (1982) DNA double strand breaks in Ehrlich ascites tumour cells at low doses of X-rays. II. Can cell death be attributed to double strand breaks? Int J Radiat Biol 42:329-338.
50. Shuker DE, Farmer PB (1992) Relevance of urinary DNA adducts as markers of carcinogen exposure. Chem Res Toxicol 5:450-460.
51. Poirier MC, Yuspa SH, Weinstein IB, Blobstein S (1977) Detection of carcinogen-DNA adducts by radiommunoassay. Nature 270:186-188.
52. Poirier MC, Santella RM, Weinstein IB, Grunberger D, Yuspa SH (1980) Quanti- tation of benzo[a]pyrene-deoxyguanosine adducts by radioimmunoassay. Cancer Res 40:412-416.
53. Baan RA, Zaalberg OB, Fichtinger-Schepman AM, Muysken-Schoen MA, Lansbergen MJ, Lohman PH (1985) Use of monoclonal and polyclonal antibodies against DNA adducts for the detection of DNA lesions in isolated DNA and in single cells. Environ Health Perspect 62:88.
54. Santella RM (1988) Monitoring human exposure to carcinogens by DNA adduct measurement. Cell Biol Toxicol 4:511-516.
55. Santella RM (1999) Immunological methods for detection of carcinogen-DNA damage in humans. Cancer Epidemiol Biomarkers Prev 8:733-739.
56. Reddy MV (2000) Methods for testing compounds for DNA adduct formation. Regul Toxicol Pharmacol 32:256-263.
57. Reddy MV, Randerath K, (1987) 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications. Environ Health Perspect 76:41-47.
58. Kumar R, Singh SK, Kole PL, Elmarakby S, Sikka HC (1995) Stereoselective metabolism of dibenz[a, h]acridine to bay-region diol epoxides by rat liver microsomes. Carcinogenesis 16:525-5130.
59. Kurisu S, Miya T, Terato H, Masaoka A, Ohyama Y, Kubo K, Ide H (2001) Quantitation of DNA damage by an aldehyde reactive probe (ARP). Nucleic Acids Symp Ser 1:45-46.
60. Nakamura J, Walker VE, Upton PB, Chiang SY, Kow YW, Swenberg JA (1998) Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions. Cancer Res 15:222-225.
61. Thompson LH, West MG (2000) XRCC1 keeps DNA from getting stranded. Mutat Res 459:1-18.
62. Morgan WF, Corcoran J, Hartmann A, Kaplan MI, Limoli CL, Ponnaiya B (1998) DNA double-strand breaks, chromosomal rearrangements, and genomic instability. Mutat Res 404:125-128.
63. Iliakis G, Blocher D, Metzger L, Pantelias G (1991) Comparison of DNA double-strand break rejoining as measured by pulsed field gel electrophoresis, neutral sucrose gradient centrifugation and non-unwinding filter elution in irradiated plateau-phase CHO cells. Int J Radiat Biol 59:927-939.
64. Daniel FB, Haas DL, Pyle SM (1985) Quantitation of chemically induced DNA strand breaks in human cells via an alkaline unwinding assay. Anal Biochem 144:390-402.
65. Dusinská M, Slamenová D (1992) Application of alkaline unwinding assay for detection of mutagen-induced DNA strand breaks. Cell Biol Toxicol 8:207-216.
66. Ahnstrom G, Erixon K (1973) Radiation-induced strand breakage in DNA from mammalian cells: strand separation in alkaline solution. Int J Radiat Biol 23:285-289.
67. Baumstark-Khan C, Griesenbach U, Rink H (1992) Comparison of DNA strand break induction in CHO cells measured by alkaline elution and by fluorometric analysis of DNA unwinding (FADU). Free Radic Res Commun 16:381-389.
68. Baumstark-Khan C, Hentschel U, Nikandrova Y, Krug J, Horneck G (2000) Fluorometric analysis of DNA unwinding (FADU) as a method for detecting repair-induced DNA strand breaks in UV-irradiated mammalian cells. Photochem Photobiol 72:477-484.
69. Baumstark-Khan C, Nikandrova Y, Krug J, Hentschel U, Horneck G (1999) Adaptation of the fluorometric analysis of DNA unwinding (FADU) for the detection of repair-induced DNA strand breaks after UV-irradiation of mammalian cells. Trends Photochem Photobiol 6:141-152.
70. Birnboim HC, Jevcak JJ (1981) Fluorometric method for rapid detection of DNA strand breaks in human white blood cells produced by low doses of radiation. Cancer Res 41:1889-1892.
71. Elmendorff-Dreikorn K, Chauvin C, Slor H, Kutzner J, Batel R, Muller WE, Schroder HC (1999) Assessment of DNA damage and repair in human peripheral blood mononuclear cells using a novel DNA unwinding technique. Cell Mol Biol 45:211-218.
72. Kanter PM, Schwartz HS (1982) A fluorescence enhancement assay for cellular DNA damage. Mol Pharmacol 22:145-151.
73. Korba BE, Hays JB, Boehmer S (1981) Sedimentation velocity of DNA in isokinetic sucrose gradients: calibration against molecular weight using fragments of defined length. Nucleic Acids Res 9:4403-4412.
74. McGrath RA, Williams RW (1966) Reconstruction in vivo of irradiated Escherichia coli deoxyribonucleic acid; the rejoining of broken pieces. Nature 212:534-535.
75. Crump PW, Fielden EM, Jenner TJ, O'Neill P (1990) A comparison of the techniques of alkaline filter elution and alkaline sucrose sedimentation used to assess DNA damage induced by 2-nitroimidazoles. Biochem Pharmacol 40:621-627.
76. Kohn KW, Grimek-Ewig RA (1973) Alkaline elution analysis, a new approach to the study of DNA single-strand interruptions in cells. Cancer Res 33:1849-1853.
77. Sutherland JC, Monteleone DC, Mugavero JH, Trunk J (1987) Unidirectional pulsed-field electrophoresis of single- and double-stranded DNA in agarose gels: analytical expressions relating mobility and molecular length and their application in the measurement of strand breaks. Anal Biochem 162:511-520.
78. Lu J, Kaeck MR, Jiang C, Garcia G, Thompson HJ (1996) A filter elution assay for the simultaneous detection of DNA double and single strand breaks. Anal Biochem 235: 227-233.
79. Olive PL (2009) Impact of the comet assay in radiobiology. Mutat Res 681:13-23.
80. Olive PL (2002) The comet assay. An overview of techniques. Methods Mol Biol 203: 179-194.
81. Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191.
82. Olive PL, Banáth JP (2009) Radiation-induced DNA double-strand breaks produced in histone-depleted tumor cell nuclei measured using the neutral comet assay. Radiat Res 142:144-152.
83. Gedik CM, Ewen SW, Collins AR (1992) Single-cell gel electrophoresis applied to the analysis of UV-C damage and its repair in human cells. Int J Radiat Biol 62:313-320.
84. De Boeck M, Touil N, De Visscher G, Vande PA, Kirsch-Volders M (2000) Validation and implementation of an internal standard in comet assay analysis. Mutat Res 469:181-197.
85. Collins AR, Dobson VL, Dusinská M, Kennedy G, Stetina R (1997) The comet assay: what can it really tell us? Mutat Res 375:183-193.
86. Collins AR, Dusinská M, Horská A (2001) Detection of alkylation damage in human lymphocyte DNA with the comet assay. Acta Biochim Pol 48:611-614.
87. Piersen CE, McCullough AK, Lloyd RS (2000) AP lyases and dRPases: commonality of mechanism. Mutat Res 459:43-53.
88. Girard PM, D'Ham C, Cadet J, Boiteux S (1998) Opposite base-dependent excision of 7, 8-dihydro-8-oxoadenine by the Ogg1 protein of Saccharomyces cerevisiae. Carcinogenesis 19:1299-1305.
89. Mohsin Ali M, Kurisu S, Yoshioka Y, Terato H, Ohyama Y, Kubo K, Ide H (2004) Detection of endonuclease III- and 8-oxoguanine glycosylase-sensitive base modifications in gamma- irradiated DNA and cells by the aldehyde reactive probe (ARP) assay. J Radiat Res 45:229-237.
90. Bonassi S, Ugolini D, Kirsch-Volders M, Stromberg U, Vermeulen R, Tucker JD (2005) Human population studies with cytogeneticbiomarkers: review of the literature and future prospectives. Environ Mol Mutagen 45:258-270.
91. Norppa H, Bonassi S, Hansteen IL, Hagmar L, Stromberg U, Rossner P, Boffetta P, Lindholm C, Gundy S, Lazutka J, Cebulska-Wasilewska A, Fabiánová E, Srám RJ, Knudsen LE, Barale R, Fucic A (2006) Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res 600:37-45.
92. van Delft JH, Baan RA, Roza L (1998) Biological effect markers for exposure to carcinogenic compound and their relevance for risk assessment. Crit Rev Toxicol 28:477-510.
93. Clements J (1995) Gene mutation assays in mammalian cells. Methods Mol Biol 43:277-286.
94. O'Neill JP, Brimer PA, Machanoff R, Hirsch GP, Hsie AW (2009) A quantitative assay of mutation induction at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells (CHO/HGPRT system): development and definition of the system. Mutat Res 45:91-101.
95. Kirkland DJ, Clements J (1998) Recommendations for spacing of test chemical concentrations in the mouse lymphomatk mutation assay (MLA). Mutat Res 415:159-163.
96. Mitchell AD, Auletta AE, Clive D, Kirby PE, Moore MM, Myhr BC (1997) The L5178Y/ tktk+/- mouse lymphoma specific gene and chromosomal mutation assay aphase III report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res 394:177-303.
97. Wang J, Heflich RH, Moore MM (2007) A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay. Mutat Res 626:185-190.
98. Corsaro CM, Migeon BR (1977) Contact-mediated communication of ouabain resistance in mammalian cells in culture. Nature 268:737-739.
99. Dayan J, Deguingand S, Truzman C (1985) Study of the mutagenic activity of 6 hepatotoxic pharmaceutical drugs in the Salmonella typhimurium microsome test, and the HGPRT and Na{thorn}/K{thorn} ATPase system in cultured mammalian cells. Mutat Res 157:1-12.
100. Moore MM, Harrington-Brock K, Doerr CL, Dearfield KL (1989) Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci. Mutagenesis 4:394-403.
101. Li AP, Aaron CS, Auletta AE, Dearfield KL, Riddle JC, Slesinski RS, Jr StankowskiLF (1991) An evaluation of the roles of mammalian cell mutationassays in the testing of chemical genotoxicity. Regul Toxicol Pharmacol 14:24-40.
102. Puck TT, Waldren CA (1987) Mutation in mammalian cells: theory and implications. Somatic Cell Mol Genet 13:405-409.
103. Waldren C, Jones C, Puck TT (1979) Measurement of mutagenesis in mammalian cells. Proc Natl Acad Sci USA 76:1358-1362.
104. Ross CD, Lim CU, Fox MH (2005) Assay to measure CD59 mutations in CHO A(L) cells using flow cytometry. Cytometry Part A 66:85-90.
105. Zhou H, Xu A, Gillispie JA, Waldren CA, Hei TK (2006) Quantification of CD59-mutants in human-hamster hybrid (AL) cells by flow cytometry. Mutat Res 594:113-119.
106. Baumstark-Khan C (2009) A calculation method of PLD recovery based on saturation kinetics. In: Riklis E (ed) Frontiers in radiation biology. VCH & Balaban, Weinheim, pp 513-520.
107. Dikomey E, Franzke J (1986) DNA repair kinetics after exposure to X-irradiation and to internal beta-rays in CHO cells. Radiat Environ Biophys 25:189-194.
108. Dikomey E, Franzke J (1986) Three classes of DNA strand breaks induced by X-irradiation and internal beta-rays. Int J Radiat Biol 50:893-908.
109. Weibezahn KF, Coquerelle T (1981) Radiation induced DNA double strand breaks are rejoined by ligation and recombination processes. Nucleic Acids Res 9:3139-3150.
110. Madle S, Dean SW, Andrae U, Brambilla G, Burlinson B, Doolittle DJ, Furihata C, Hertner T, McQueen CA, Mori H (1994) Recommendations for the performance of UDS tests in vitro and in vivo. Mutat Res 312:263-285.
111. Mitchell AD, Casciano DA, Meltz ML, San RH, Williams GM, von Halle ES (1983) Unscheduled DNA synthesis tests. A report of the U.S. Environmental protection agency gene-tox program. Mutat Res 123:363-410.
112. Efeyan A, Serrano M (2007) p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 6:1006-1010.
113. Gomez-Lazaro M, Fernandez-Gomez FJ, Jordán J, (2004) p53: twenty five years understanding the mechanism of genome protection. J Physiol Biochem 60:287-307.
114. Janus F, Albrechtsen N, Dornreiter I, Wiesmuller L, Grosse F, Deppert W (1999) The dual role model for p53 in maintaining genomic integrity. Cell Mol Life Sci 55:12-27.
115. Wu X, Ranganathan V, Weisman DS, Ciccone DN, O'Neill TB, Crick KE, Pierce KA, Lane WS, Rathbun G, Livingston DM, Weaver DT (2000) ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 405:477-482.
116. Lee H, Kwak HJ, Cho IT, Park SH, Lee CH (2009) S1219 residue of 53BP1 is phosphorylated by ATM kinase upon DNA damage and required for proper execution of DNA damage response. Biochem Biophys Res Commun 378:32-36.
117. Xu B, O'Donnell AH, Kim ST, Kastan MB (2002) Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res 62:4588-4591.
118. O'Reilly MA (2005) Redox activation of p21Cip1/WAF1/Sdi1: a multifunctional regulator of cell survival and death. Antioxid Redox Signal 7:108-118.
119. Mazumder S, Plesca D, Almasan A (2007) A jekyll and hyde role of cyclin E in the genotoxic stress response: switching from cell cycle control to apoptosis regulation. Cell Cycle 6: 1437-1442.
120. Mukherjee B, Kessinger C, Kobayashi J, Chen BP, Chatterjee A, Burma S (2006) DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. DNA Repair 5:575-590.
121. Liebermann DA, Hoffman B (2008) Gadd45 in stress signaling. J Mol Signal 3:15.
122. Solier S, Sordet O, Kohn KW, Pommier Y (2009) Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways. Mol Cell Biol 29:68-82.
123. Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311-322.
124. Wu X, Lieber MR (1996) Protein-protein and protein-DNA interaction regions within the DNA end-binding protein Ku70-Ku86. Mol Cell Biol 16:5186-5193.
125. Agrawal A, Yang J, Murphy RF, Agrawal DK (2006) Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer. Environ Mol Pathol 81:115-122.
126. Williams RS, Williams JS, Tainer JA (2007) Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template. Biochem Cell Biol 85:509-520.
127. Marcelain K, De La Torre C, González P, Pincheira J (2009) Roles of nibrin and AtM/ATR kinases on the G2 checkpoint under endogenous or radio-induced DNA damage. Biol Res 38:179-185.
128. Besson A, Yong VW (2001) Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas. J Neurooncol 51:245-264.
129. Essers J, Theil AF, Baldeyron C, van Cappellen WA, Houtsmuller AB, Kanaar R, Vermeulen W (2005) Nuclear dynamics of PCNA in DNA replication and repair. Mol Cell Biol 25:9350-9359.
130. Digweed M, Rothe S, Demuth I, Scholz R, Schindler D, Stumm M, Grompe M, Jordan A, Sperling K (2002) Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis 23:1121-1126.
131. Meek DW (1994) Post-translational modification of p53. Semin Cancer Biol 5:203-210.
132. Rocha S, Garrett MD, Campbell KJ, Schumm K, Perkins ND (2005) Regulation of NF- kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J 24:1157-1169.
133. Pilch DR, Sedelnikova OA, Redon C, Celeste A, Nussenzweig A, Bonner WM (2003) Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. Biochem Cell Biol 81:123-129.
134. Iijima K, Ohara M, Seki R, Tauchi H (2008) Dancing on damaged chromatin: functions of ATM and the RAD50/MRE11/NBS1 complex in cellular responses to DNA damage. J Radiat Res 49:451-464.
135. Kang J, Ferguson D, Song H, Bassing C, Eckersdorff M, Alt FW, Xu Y (2009) Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Mol Cell Biol 25:661-670.
136. Ward IM, Minn K, Jorda KG, Chen J (2003) Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX. J Biol Chem 278:19579-19582.
137. Rashi-Elkeles S, Elkon R, Weizman N, Linhart C, Amariglio N, Sternberg G, Rechavi G, Barzilai A, Shamir R, Shiloh Y (2006) Parallel induction of ATM-dependent pro- and antiapoptotic signals in response to ionizing radiation in murine lymphoid tissue. Oncogene 25:1584-1592.
138. Feng Z, Hu W, Rajagopal G, Levine AJ (2008) The tumor suppressor p53: cancer and aging. Cell Cycle 7:842-847.
139. Gottlieb TM, Oren M (1996) p53 in growth control and neoplasia. Biochim Biophys Acta 1287:77-102.
140. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI (2009) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
141. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3:221-227.
142. Papa S, Zazzeroni F, Pham CG, Bubici C, Franzoso G (2004) Linking JNK signaling to NF-kappaB: a key to survival. J Cell Sci 117:5197-5208.
143. Habraken Y, Piette J (2006) NF-kappaB activation by double-strand breaks. Biochem Pharmacol 72:1132-1141.
144. Oberst A, Bender C, Green DR (2008) Living with death: the evolution of the mitochondrial pathway of apoptosis in animals. Cell Death Different 15:1139-1146.
145. 0-deoxyguanosine, increased 3-nitrotyro- sine, and alteration of p53 gene. J Toxicol Environ Health Part B Crit Rev 4:313-332.
146. Bradbury DA, Simmons TD, Slater KJ, Crouch SP (2000) Measurement of the ADP:ATP ratio in human leukaemic cell lines can be used as an indicator of cell viability, necrosis and apoptosis. J Immunol Methods 240:79-92.
147. Sundberg SA (2000) High-throughput and ultra-high-throughput screening: solution-and cell-based approaches. Curr Opin Biotechnol 11:47-53.
148. Fischbach M, Bromley P (2001) Recombinant cell lines for stress reporter assays. Cell Biol Toxicol 17:335-351.
149. King AV, Jones PA (2003) In-house assessment of a modified in vitro cytotoxicity assay for higher throughput estimation of acute toxicity. Toxicol In Vitro 17:717-722.
150. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589-601.
151. Riss TL, Moravec RA (2004) Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev Technol 2:51-62.
152. Jost LM, Kirkwood JM, Whiteside TL (1992) Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J Immunol Methods 147:153-165.
153. Fan F, Wood KV (2007) Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol 5:127-136.
154. Wesierska-Gadek J, Gueorguieva M, Ranftler C, Zerza-Schnitzhofer G (2005) A new multiplex assay allowing simultaneous detection of the inhibition of cell proliferation and induction of cell death. J Cell Biochem 96:1-7.
155. O'Brien MA, Moravec RA, Riss TL, Bulleit RF (2008) Homogeneous, bioluminescent proteasome assays. Methods Mol Biol 414:163-181.
156. Baumstark-Khan C, Horneck G (2007) Results from the "Technical workshop on genotoxicity biosensing" on the microscale fluorometric assay of DNA-unwinding. Anal Chim Acta 593:75-81.
157. Ullmann K, Muller C, Steinberg P (2008) Two essential modifications strongly improve the performance of the Fast Micromethod to identify DNA single- and double-strand breaks. Arch Toxicol 82:861-867.
158. Frieauff W, Hartmann A, Suter W (2001) Automatic analysis of slides processed in the comet assay. Mutagenesis 15:133-137.
159. Kiskinis E, Suter W, Hartmann A (2002) High throughput comet assay using 96-well plates. Mutagenesis 17:37-43.
160. Ashcroft R, Lopez P (2000) Commercial high speed machines opennew opportunities in high throughput flow cytometry (HTFC). J Immunol Methods 243:13-24.
161. Forand A, Dutrillaux B, Bernardino-Sgherri J (2004) Gamma-H2AX expression pattern in non-irradiated neonatal mouse germ cells and after low-dose gamma-radiation: relationships between chromatid breaks and DNA double-strand breaks. Biol Reprod 71:643-649.
162. Abraham VC, Taylor DL, Haskins JR (2004) High content screening applied to large-scale cell biology. Trends Biotechnol 22:15-22.
163. Cervinka M, Cervinkova Z, Rudolf E (2008) The role of time-lapse fluorescent microscopy in the characterization of toxic effects in cell populations cultivated in vitro. Toxicol In Vitro 22:1382-1386.
164. Evans JG, Matsudaira P (2007) Linking microscopy and high content screening in large-scale biomedical research. Methods Mol Biol 356:33-38.
165. Rausch O (2006) High content cellular screening. Curr Opin Chem Biol 10:316-329.
166. Diaz D, Scott A, Carmichael P, Shi W, Costales C (2007) Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells. Mutat Res 630:1-13.
167. He YD (2006) Genomic approach to biomarker identification and its recent applications. Cancer Biomarkers 2:103-133.
168. Leighton JK (2005) Application of emerging technologies in toxicology and safety assessment: regulatory perspectives. Int J Toxicol 24:153-155.
169. Aardema M J, MacGregor JT (2002) Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. Mutat Res 499:13-25.
170. Waters MD, Fostel JM (2004) Toxicogenomics and systems toxicology: aims and prospects. Nat Rev Genet 5:936-948.
171. Xu ZL, Mizuguchi H, Ishii-Watabe A, Uchida E, Mayumi T, Hayakawa T (2001) Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene 272: 149-156.
172. López-Maury L, Marguerat S, Bähler J (2008) Tuning gene expression to changing environments: from rapid responses to evolutionary adaptation. Nat Rev Genet 9:583-593.
173. Edelman GM, Meech R, Owens GC, Jones FS (2000) Synthetic promoter elements obtained by nucleotide sequence variation and selection for activity. Proc Nat Acad Sci USA 97:3038-3043.
174. Alcaraz-Pérez F, Mulero V, Cayuela ML (2008) Application of the dual-luciferase reporter assay to the analysis of promoter activity in Zebrafish embryos. BMC Biotechnol 8:81.
175. Arnone MI, Dmochowski IJ, Gache C (2004) Using reporter genes to study cis-regulatory elements. Methods Cell Biol 74:652.
176. Schlaeger EJ, Kitas EA, Dorn A (2003) SEAP expression in transiently transfected mammalian cells grown in serum-free suspension culture. Cytotechnology 42:47-55.
177. Michelini E, Cevenini L, Mezzanotte L, Ablamsky D, Southworth T, Branchini BR, Roda A (2008) Combining intracellular and secreted bioluminescent reporter proteins for multicolor cell-based assays. Photochem Photobiol Sci 7:212-217.
178. Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO (2005) Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11:435-443.
179. Baumstark-Khan C, Hellweg CE, Horneck G (2002) On the suitability of red and enhanced green fluorescent protein (DsRed/EGFP) as reporter combination. In: Hoffmann K-H (ed), Springer, Berlin, pp 1-13.
180. Hellweg CE, Baumstark-Khan C, Rettberg P, Horneck G (2001) The suitability of enhanced green fluorescent protein (EGFP) as reporter component for bioassays. Anal Chim Acta 426:175-184.
181. Shaner NC, Steinbach PA, Tsien RY (2005) A guide to choosing fluorescent proteins. Nat Methods 2:905-909.
182. Jeng MH, Shupnik MA, Bender TP, Westin EH, Bandyopadhyay D, Kumar R, Masamura S, Santen RJ (1998) Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology 139:4164-4174.
183. Donato MT, Lahoz A, Castell JV, Gómez-Lechón MJ(2008)Cell lines:a tool for in vitro drug metabolism studies. Curr Drug Metab 9:1-11.
184. Scheuenpflug J, Krebsfänger N, Doehmer J (2005) Heterologous co-expression of human cytochrome P450 1A2 and polymorphic forms of N-acetyltransferase 2 for studies on aromatic amines in V79 Chinese hamster cells. Altern Lab Anim 33:561-577.
185. Zhuge J, Luo Y, Yu YN (2003) Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line. World J Gastroenterol 9:2732-2736.
186. Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, Guguen-Guillouzo C (2007) The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem-Biol Interact 168:66-73.
187. Chen JJ (2007) Key aspects of analyzing microarray gene-expression data. Pharmacogenomics 8:473-482.
188. Lettieri T (2006) Recent applications of DNA microarray technology to toxicology and ecotoxicology. Environ Health Perspect 114:4-9.
189. Coombe DR, Nakhoul AM, Stevenson SM, Peroni SE, Sanderson CJ (1998) Expressed luciferase viability assay (ELVA) for the measurement of cell growth and viability. J Immunol Methods 215:145-150.
190. Elliott G, McGrath J, Crockett-Torabi E (2000) Green fluorescent protein: a novel viability assay for cryobiological applications. Cryobiology 40:360-369.
191. Baumstark-Khan C, Hellweg CE, Palm M, Horneck G (2001) Enhanced green fluorescent protein (EGFP) for space radiation research using mammalian cells in the International Space Station. Phys Med 17:210-214.
192. Hellweg CE, Baumstark-Khan C, Horneck G (2001) Enhanced green fluorescent protein as reporter protein for biomonitoring of cytotoxic effects in mammalian cells. Anal Chim Acta 427:191-199.
193. Hellweg CE, Arenz A, Baumstark-Khan C (2007) Assessment of space environmental factors by cytotoxicity bioassays. Acta Astronaut 60:525-533.
194. Quiñones A, Rainov NG (2001) Identification of genotoxic stress in human cells by fluorescent monitoring of p53 expression. Mutat Res 494:73-85.
195. Gorbunov NV, Morris JE, Greenberger JS, Thrall BD (2002) Establishment of a novel clonal murine bone marrow stromal cell line for assessment of p53 responses to genotoxic stress. Toxicology 179:257-266.
196. Ohno K, Ishihata K, Tanaka-Azuma Y, Yamada T (2008) A genotoxicity test system based on p53R2 gene expression in human cells: assessment of its reactivity to various classes of genotoxic chemicals. Mutat Res 656:27-35.
197. Ohno K, Tanaka-Azuma Y, Yoneda Y, Yamada T (2005) Genotoxicity test system based on p53R2 gene expression in human cells: examination with 80 chemicals. Mutat Res 588: 47-57.
198. Arenz A (2007) Design and validation of a bioassay for detection of induced gene activity to be used at the International Space Station, Faculty of Mathematics and Natural Sciences, University of Cologne, Germany.
199. Hellweg CE, Baumstark-Khan C, Horneck G (2003) Generation of stably transfected mammalian cell lines as fluorescent screening assay for NF-kappaB activation-dependent gene expression. J Biomol Screening 8:511-521.
200. Hellweg CE, Arenz A, Bogner S, Schmitz C, Baumstark-Khan C (2006) Activation of nuclear factor kappa B by different agents: influence of culture conditions in a cell-based assay. Ann NY Acad Sci 1091:191-204.
201. Baumstark-Khan C, Hellweg CE, Arenz A, Meier MM (2005) Cellular monitoring of the nuclear factor kappaB pathway for assessment of space environmental radiation. Radiat Res 1664:527-530.
202. Hellweg CE, Baumstark-Khan C (2007) Detection of UV-induced activation of NF-kappaB in a recombinant human cell line by means of enhanced green fluorescent protein (EGFP). Radiat Environ Biophys 46:269-279.
203. Todd MD, Lee MJ, Williams JL, Nalezny JM, Gee P, Benjamin MB, Farr SB (1995) Stress responses to DNA damaging agents in the human colon carcinoma cell line RKO. Fundam Appl Toxicol 28:118-128.
204. Hastwell PW, Chai LL, Roberts KJ, Webster TW, Harvey JS, Rees RW, Walmsley RM (2006) High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay. Mutat Res 607:160-175.
205. Walmsley RM (2008) GADD45a-GFP GreenScreen HC genotoxicity screening assay. Expert Opin Drug Metab Toxicol 4:827-835.
206. Beard SE, Capaldi SR, Gee P (2009) Stress responses to DNA damaging agents in the human colon carcinoma cell line RKO. Mutat Res 371:1-13.
207. O'Connell-Rodwell CE, Shriver D, Simanovskii DM, McClure C, Cao YA, Zhang W, Bachmann MH, Beckham JT, Jansen ED, Palanker D, Schwettman HA, Contag CH (2004) A genetic reporter of thermal stress defines physiologic zones over a defined temperature range. FASEB J 18:264-271.
208. Fischbach M, Sabbioni E, Bromley P (1993) Induction of the human growth hormone gene placed under human hsp70 promoter control in mouse cells: a quantitative indicator of metal toxicity. Cell Biol Toxicol 9:177-188.
209. Yoshizumi M, Wang H, Hsieh CM, Sibinga NE, Perrella MA, Lee ME (1997) Down-regulation of the cyclin A promoter by transforming growth factor-beta1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclic AMP-responsive element-binding protein. J Biol Chem 272:22259-22264.
210. Imreh G, Beckman M, Iverfeldt K, Hallberg E (1998) Noninvasive monitoring of apoptosis versus necrosis in a neuroblastoma cell line expressing a nuclear pore protein tagged with the green fluorescent protein. Exp Cell Res 238:371-376.
211. Mahajan NP, Harrison-Shostak DC, Michaux J, Herman B (1999) Novel mutant green fluorescent protein protease substrates reveal the activation of specific caspases during apoptosis. Chem Biol 6:401-409.
212. Strebel A, Harr T, Bachmann F, Wernli M, Erb P (2001) Green fluorescent protein as a novel tool to measure apoptosis and necrosis. Cytometry 43:126-133.
213. Johnson JM, Latimer JJ (2005) Analysis of DNA repair using transfection-based host cell reactivation. Methods Mol Biol 291:321-335.
214. Stoklosa T, Poplawski T, Koptyra M, Nieborowska-Skorska M, Basak G, Slupianek A, Rayevskaya M, Seferynska I, Herrera L, Blasiak J, Skorski T (2008) BCR/ABL inhibits mis-match repair to protect from apoptosis and induce point mutations. Cancer Res 68:2576-2580.
215. Zhou B, Huang C, Yang J, Lu J, Dong Q, Sun LZ (2009) Preparation of heteroduplex EGFP plasmid for in vivo mismatch repair activity assay. Anal Biochem 388:167-169.
216. Roguev A, Russev G (2000) Two-wavelength fluorescence assay for DNA repair. Anal Biochem 287:313-318.
217. Collis SJ, Sangar VK, Tighe A, Roberts SA, Clarke NW, Hendry JH, Margison GP (2002) Development of a novel rapid assay to assess the fidelity of DNA double-strand-break repair in human tumour cells. Nucleic Acids Res 30:e1.
218. Slebos RJ, Taylor JA (2001) A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines. Biochem Biophys Res Commun 281:212-219.